These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 5018655

  • 1. Gut lesions in Fabry's disease without a rash.
    Flynn DM, Lake BD, Boothby CB, Young EP.
    Arch Dis Child; 1972 Feb; 47(251):26-33. PubMed ID: 5018655
    [Abstract] [Full Text] [Related]

  • 2. Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes.
    Avila JL, Convit J, Velazquez-Avila G.
    Br J Dermatol; 1973 Aug; 89(2):149-57. PubMed ID: 4726891
    [No Abstract] [Full Text] [Related]

  • 3. Relief of pain of Fabry's disease by diphenylhydantoin.
    Lockman LA, Hunninghake DB, Krivit W, Desnick RJ.
    Neurology; 1973 Aug; 23(8):871-5. PubMed ID: 4578349
    [No Abstract] [Full Text] [Related]

  • 4. Fabry's disease (ceramide trihexosidase deficiency): diagnostic confirmation by analysis of dental pulp.
    Desnick SJ, Witkop CJ, Krivit W, Thies JK, Desnick RJ.
    Arch Oral Biol; 1972 Oct; 17(10):1473-9. PubMed ID: 4507778
    [No Abstract] [Full Text] [Related]

  • 5. A kidney transplant patient with Fabry's disease. Unusual features.
    Suros J, Woods JE, Anderson CF, Frohnert PP, Kazmier FJ, Holley KE, Riley FC, DeWeed JH.
    Arch Surg; 1973 Feb; 106(2):231-3. PubMed ID: 4568657
    [No Abstract] [Full Text] [Related]

  • 6. Anderson-Fabry dyslipidosis.
    Johnson ML.
    Proc R Soc Med; 1972 Sep; 65(9):768-70. PubMed ID: 5085061
    [No Abstract] [Full Text] [Related]

  • 7. Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.
    Romeo G, Migeon BR.
    Science; 1970 Oct 09; 170(3954):180-1. PubMed ID: 5466114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Biochemistry of Fabry's disease].
    Kint JA, Dacremont G.
    Arch Belg Dermatol Syphiligr; 1972 Oct 09; 28(3):245-50. PubMed ID: 4664703
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Fabry's disease].
    Wolfe LS, Mossard JM, Jossot G.
    Presse Med (1893); 1970 Nov 07; 78(47):2051-2. PubMed ID: 5483194
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ceramide trihexosidosis (fabry's disease) without skin lesions.
    Clarke JT, Knaack J, Crawhall JC, Wolfe LS.
    N Engl J Med; 1971 Feb 04; 284(5):233-5. PubMed ID: 5539345
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.
    Philippart M, Franklin SS, Gordon A.
    Ann Intern Med; 1972 Aug 04; 77(2):195-200. PubMed ID: 4565790
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.